BRICKELL BIOTECH INC (BBI) Forecast, Price Target & Analyst Ratings
NASDAQ:BBI • US10802T2042
2.35 USD
+0.05 (+2.17%)
Last: Sep 7, 2022, 08:17 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BRICKELL BIOTECH INC (BBI).
Forecast Snapshot
Consensus Price Target
$18.19
+ 674.04% Upside
Next Earnings Forecast
Release DateNov 7, 2022
PeriodQ3 / 2022
EPS Estimate-$1.87
Revenue Estimate208.737K
ChartMill Buy Consensus
82.50%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$18.19
Upside
+ 674.04%
From current price of $2.35 to mean target of $18.19, Based on 8 analyst forecasts
Low
$4.04
Median
$4.59
High
$47.25
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
8 Wall Street analysts provided a forecast for the next 12 months for BBI. The average price target is 18.19 USD. This implies a price increase of 674.04% is expected in the next year compared to the current price of 2.35.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.50%
BBI was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BBI.
In the previous month the buy percentage consensus was at a similar level.
BBI was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-08-16 | HC Wainwright & Co. | Maintains | Buy |
| 2022-05-13 | Lake Street | Downgrade | Buy -> Hold |
| 2022-03-08 | William Blair | Initiate | Outperform |
| 2022-01-18 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateNov 7, 2022
PeriodQ3 / 2022
EPS Estimate-$1.87
Revenue Estimate208.737K
Revenue Q2Q58.13%
EPS Q2Q74.05%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
BBI is expected to report earnings on 11/7/2022. The consensus EPS estimate for the next earnings is -1.87 USD and the consensus revenue estimate is 208.74K USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.92M 388.89% | 1.82M -77.02% | 404K -77.80% | 6.215M 1,438.25% | 7.188M 15.66% | 6.06M -15.69% | 5.999M -1.00% | 5.998M -0.01% | |
| EBITDA YoY % growth | -19.64M -8.45% | -20.97M -6.77% | -40.222M -91.81% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -19.67M -7.72% | -20.98M -6.66% | -40.244M -91.82% | -21.446M 46.71% | -22.837M -6.49% | -26.159M -14.54% | -23.176M 11.40% | -20.739M 10.52% | |
| Operating Margin | -248.36% | -1,152.75% | -9,961.39% | -345.09% | -317.72% | -431.67% | -386.33% | -345.75% | |
| EPS YoY % growth | N/A | N/A | -23.85 26.09% | -7.00 70.65% | -6.85 2.16% | -6.85 | -6.85 -0.08% | -6.93 -1.08% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.87 74.05% | -1.11 58.85% | -1.50 58.20% | -1.55 -15,353.00% | -0.40 78.38% | -1.45 -30.91% | -1.68 -11.41% | -1.88 -21.57% | -1.07 -165.00% | -2.21 -52.08% |
| Revenue Q2Q % growth | 208.737K 58.13% | 1.557M 1,397.20% | 318.15K 245.82% | 505K -84.05% | 4.545M 2,077.38% | 626.2K -59.78% | 505K 58.73% | 505K | 4.545M | 505K -19.35% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.741M 57.02% | -4.719M 25.15% | -8.757M 6.91% | 4.328M 214.20% | -10.666M -85.77% | -10.812M -129.11% | N/A | N/A | N/A | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
19.65%
EPS Next 5 Year
11.32%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
136.30%
Revenue Next 5 Year
67.18%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BRICKELL BIOTECH INC / BBI Forecast FAQ
What do analysts expect the price target to be for BRICKELL BIOTECH INC (BBI)?
8 analysts have analysed BBI and the average price target is 18.19 USD. This implies a price increase of 674.04% is expected in the next year compared to the current price of 2.35.
What is the next earnings date for BBI stock?
BRICKELL BIOTECH INC (BBI) will report earnings on 2022-11-07.
What are the consensus estimates for BBI stock next earnings?
The consensus EPS estimate for the next earnings of BRICKELL BIOTECH INC (BBI) is -1.87 USD and the consensus revenue estimate is 208.74K USD.
Can you provide the expected long term growth rate for BRICKELL BIOTECH INC stock?
The expected long term growth rate for BRICKELL BIOTECH INC (BBI) is 136.3%.